在PIK3CA突变的食道状细胞癌中免疫细胞透和药物敏感性:TCGA数据库分析分析

Shuo He1, Qing Liu2, Shujuan Luo1

  • 1State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi 830011, China; Department of Pathology, Basic Medicine College, Xinjiang Medical University, Urumqi 830017, China.

Human immunology
|November 3, 2024
PubMed
概括

食道状细胞癌 (ESCC) 中的PIK3CA突变与增加的瘤突变负担和特定的免疫细胞透相关. 在ESCC中发生突变的PIK3CA可能会对p38/JNK MAPK抑制剂产生抗性.